HOME >> BIOLOGY >> NEWS
Researchers Develop New Treatment For Hepatitis B And C As Nation Anticipates Surge In Number Of Cases

LOS ANGELES (April 6, 1999) -- Scientists are studying new treatments to combat two viruses that cause chronic liver inflammation, can have catastrophic consequences, and are expected to become increasingly devastating over the next decade. Inflammation of the liver, or hepatitis, can result from a variety of activities or events such as drug and alcohol abuse, ingestion of toxic chemicals or medications, or exposure to one of several viruses that affect the liver.

Of the six known liver-related viruses, referred to as hepatitis A, B, C, D, E, and G, the hepatitis B and C strains pose the greatest threat because they can become chronic diseases, are easily transmitted and they often remain unrecognized until they have caused significant damage to the liver.

In fact, because the liver does not contain nerve endings to send signals of pain to the brain, patients can live without symptoms for many years from the time of infection to diagnosis. By then, scarring, or cirrhosis, of the liver may be so widespread and function so diminished that transplantation offers the only prospect of survival. Liver damage due to hepatitis B or C also can lead to liver cancer, called hepatocellular carcinoma.

"Patients with liver disease can appear relatively well from their perspective, as well as from the perspective of their families and their health-care providers until they reach a stage of complications," according to John M. Vierling, M.D., director of Hepatology at Cedars-Sinai Medical Center, medical director of the hospital's liver transplantation program, and chair of the board of directors of the American Liver Foundation.

Chronic hepatitis B is currently blamed for about 6,000 deaths a year in the United States, Dr. Vierling said. Hepatitis C is responsible for 10,000 deaths but those numbers are expected to jump sharply. "With hepatitis C, we have excellent evidence from the federal government that this rate could rise to approximately 30,000 deaths p
'"/>

Contact: Sandra Van
Sandy@VanCommunications.com
1-800-396-1002
Cedars-Sinai Medical Center
6-Apr-1999


Page: 1 2 3 4 5

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Researchers identify protein promoting vascular tumor growth
4. Researchers devise potent new tools to curb ivory poaching
5. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
6. Researchers ID chlorophyll-regulating gene
7. Researchers develop fast track way to discover how cells are regulated
8. Researchers identify distinctive signature for metastatic prostate cancer
9. Researchers report new gene test for isolated cleft lip and palate
10. Researchers discover why mutant gene causes colon cancer
11. Researchers identify the genomes controlling elements

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2020)... ... June 23, 2020 , ... ... antibody development services, today announced that the company has received ISO9001:2015 certification ... pharmaceutical, diagnostics, and research industries. The decision to pursue ISO9001 accreditation demonstrates ...
(Date:6/23/2020)... ... June 22, 2020 , ... The field of quantitation ... binding assays (LBA) have dominated this area. However, the use of mass spectrometry in ... This now necessitates the question “How do you choose which approach to use (LBA ...
(Date:6/23/2020)... ... June 23, 2020 , ... In its June 22 online post, ... Dr. James L. Sherley, M.D., Ph.D., founder and director of stem cell biotechnology company ... on June 16 that starting July 5 it would begin offering free ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... ... July 09, 2020 , ... ... of Technology (MIT) has expanded the company’s exclusive license to include clinical ... the point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ ...
(Date:7/10/2020)... ... July 09, 2020 , ... Sentien ... announced the hiring of Allen R. Nissenson, M.D., F.A.C.P., as its Chief Medical ... development of Sentien’s lead product, SBI-101. Dr. Nissenson serves as an Emeritus ...
(Date:7/7/2020)... BOSTON (PRWEB) , ... July 06, 2020 , ... ... Innovative Practices Awards. Entries from Roche, Eli Lilly, Bristol-Myers Squibb, the University of ... Since 2003, Bio-IT World has hosted an elite awards program, highlighting outstanding examples ...
(Date:7/1/2020)... ... June 29, 2020 , ... ... procured purchasing contracts to its membership, recently named BioFit Engineered Products ... the opportunity to purchase ergonomic seating, cafeteria tables, book trucks and carts at ...
Breaking Biology Technology:
Cached News: